Deerfield Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.4M Hold
21,231,974
1.11% 24
2025
Q1
$45.6M Hold
21,231,974
0.9% 27
2024
Q4
$82.2M Hold
21,231,974
1.56% 18
2024
Q3
$139M Hold
21,231,974
2.08% 9
2024
Q2
$154M Hold
21,231,974
2.56% 8
2024
Q1
$161M Buy
21,231,974
+4,290,617
+25% +$32.6M 2.8% 4
2023
Q4
$77.1M Hold
16,941,357
1.42% 21
2023
Q3
$66.9M Hold
16,941,357
1.47% 18
2023
Q2
$53M Hold
16,941,357
1.13% 26
2023
Q1
$76.7M Hold
16,941,357
1.71% 17
2022
Q4
$70M Hold
16,941,357
1.45% 25
2022
Q3
$54.2M Buy
16,941,357
+11,111,108
+191% +$35.6M 1.08% 30
2022
Q2
$11.4M Hold
5,830,249
0.24% 73
2022
Q1
$23.6M Hold
5,830,249
0.53% 45
2021
Q4
$62.9M Hold
5,830,249
1.32% 23
2021
Q3
$67.2M Hold
5,830,249
1.31% 20
2021
Q2
$57.3M Buy
5,830,249
+685,710
+13% +$6.73M 1.02% 24
2021
Q1
$75.2M Hold
5,144,539
1.58% 16
2020
Q4
$110M Hold
5,144,539
2.18% 9
2020
Q3
$78M Hold
5,144,539
1.9% 13
2020
Q2
$66.1M Buy
+5,144,539
New +$66.1M 1.93% 14
2016
Q3
Sell
-254,634
Closed -$18.3M 98
2016
Q2
$18.3M Hold
254,634
0.72% 48
2016
Q1
$20.4M Buy
254,634
+184,329
+262% +$14.8M 0.87% 41
2015
Q4
$5.31M Buy
70,305
+24,182
+52% +$1.83M 0.22% 77
2015
Q3
$17.7M Sell
46,123
-37,845
-45% -$14.5M 0.68% 52
2015
Q2
$34.9M Sell
83,968
-3,547
-4% -$1.47M 1.16% 27
2015
Q1
$41.6M Buy
+87,515
New +$41.6M 1.35% 18